Survivin is a potential mediator of prostate cancer metastasis

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1095-1103

  Zhang, Min ^a   Coen, John J ^b   Suzuki, Yoshiyuki ^a   Siedow, Michael R ^a   Niemierko, Andrzej ^a   Khor, Li Yan ^d   Pollack, Alan ^c   Zhang, Yifen ^b   Zietman, Anthony L ^b   Shipley, William U ^b   Chakravarti, Arnab ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metastasis; Prostate cancer; Survivin

Indexed keywords

CELL MOTILITY; CYTOSKELETONS; DEFINITIVE RADIOTHERAPY; DISTANT METASTASIS; DOMINANT-NEGATIVE MUTANTS; EXTERNAL BEAM RADIATION THERAPY; IN-VITRO; IN-VIVO; INDEPENDENT PREDICTORS; INVASIVENESS; MASSACHUSETTS; METASTASIS; MICROTUBULES; MULTI VARIATE ANALYSIS; OVER-EXPRESSION; PRECLINICAL STUDIES; PROSTATE CANCER; PROSTATE CANCER CELLS; PROSTATE CANCERS; REPLICATION-DEFICIENT ADENOVIRUS; SHORT HAIRPIN RNA (SHRNA); SURVIVIN; THERAPEUTIC TARGETS; UNIVARIATE ANALYSIS;

DISEASES; HOSPITALS; MULTIVARIANT ANALYSIS; PATHOLOGY; PHOSPHORYLATION; RNA;

RADIOTHERAPY;

SHORT HAIRPIN RNA; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL MOTILITY; CELL POLARITY; CYTOSKELETON; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MIGRATION ASSAY; GENETICS; INVERTED REPEAT; METABOLISM; METASTASIS; MIDDLE AGED; MOUSE; PATHOLOGY; PHYSIOLOGY; PROSTATIC NEOPLASMS; SCID MOUSE; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; FOLLOW-UP STUDIES; HUMANS; INVERTED REPEAT SEQUENCES; MALE; MICE; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; INHIBITOR OF APOPTOSIS PROTEINS;

EID: 77958465419     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.007     Document Type: Article

References (43)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
2. A. Chakravarti, and G.G. Zhai Molecular and genetic prognostic factors of prostate cancer World J Urol 21 2003 265 274
3. J.T. Isaacs Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer Am J Pathol 150 1997 1511 1521
4. R.V. Gopalkrishnan, D.C. Kang, and P.B. Fisher Molecular markers and determinants of prostate cancer metastasis J Cell Physiol 189 2001 245 256
5. D.C. Altieri Validating survivin as a cancer therapeutic target Nat Rev Cancer 3 2003 46 54
6. F. Li Survivin study: What is the next wave? J Cell Physiol 197 2003 8 29
7. K.R. McEleny, R.W. Watson, and R.N. Coffey Inhibitors of apoptosis proteins in prostate cancer cell lines Prostate 51 2002 133 140
8. H. Kishi, M. Igawa, and N. Kikuno Expression of the survivin gene in prostate cancer: Correlation with clinicopathological characteristics, proliferative activity and apoptosis J Urol 171 2004 1855 1860
9. S.F. Shariat, Y. Lotan, and H. Saboorian Survivin expression is associated with features of biologically aggressive prostate carcinoma Cancer 100 2004 751 757
10. M. Zhang, D.E. Latham, and M.A. Delaney Survivin mediates resistance to antiandrogen therapy in prostate cancer Oncogene 24 2005 2474 2482
11. M. Zhang, N. Mukherjee, and R.S. Bermudez Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo Prostate 64 2005 293 302
12. A.L. Zietman, C.S. Chung, and J.J. Coen 10-Year outcome for men with localized prostate cancer treated with external radiation therapy: Results of a cohort study J Urol 171 2004 210 214
13. M.B. Gretzer, B.J. Trock, and M. Han A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria J Urol 168 2002 1419 1422
14. M. Zhang, A. Ho, and E.H. Hammond Prognostic value of survivin in locally advanced prostate cancer: Study based on RTOG 8610 Int J Radiat Oncol Biol Phys 73 2009 1033 1042
15. C.J. Strock, J.I. Park, and E.K. Nakakura Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells Cancer Res 66 2006 7509 7515
16. M. Hamano, H. Kuramochi, and N. Nihei Mechanisms of metastasis suppression by introduction of human chromosome 10 into rat prostate cancer Asian J Androl 4 2002 123 129 (Pubitemid 34716436)
17. A.C. Gao, W. Lou, and J.T. Dong CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13 Cancer Res 57 1997 846 849
18. M.J. Bussemakers, R.J. van Moorselaar, and L.A. Giroldi Decreased expression of E-cadherin in the progression of rat prostatic cancer Cancer Res 52 1992 2916 2922
19. G. Ambrosini, C. Adida, and G. Sirugo Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting J Biol Chem 273 1998 11177 11182
20. A. Chakravarti, G.G. Zhai, and M. Zhang Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms Oncogene 23 2004 7494 7506
21. M. Zhang, S. Altuwaijri, and S. Yeh RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness Oncogene 23 2004 3080 3088
22. E.L.M.P. Kaplan Non parametric estimation from incomplete observations J Am stat assoc 53 1958 457 816
23. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
24. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
25. Y. Iwamoto, and Y. Sugioka Use of a reconstituted basement membrane to study the invasiveness of tumor cells Adv Exp Med Biol 324 1992 141 149
26. A.J. Ridley, M.A. Schwartz, and K. Burridge Cell migration: Integrating signals from front to back Science 302 2003 1704 1709
27. M. Vicente-Manzanares, D.J. Webb, and A.R. Horwitz Cell migration at a glance J Cell Sci 118 2005 4917 4919
28. J. Luders, and T. Stearns Microtubule-organizing centres: A re-evaluation Nat Rev Mol Cell Biol 8 2007 161 167
29. O.C. Rodriguez, A.W. Schaefer, and C.A. Mandato Conserved microtubule-actin interactions in cell movement and morphogenesis Nat Cell Biol 5 2003 599 609
30. S.F. Winter, A.B. Cooper, and N.M. Greenberg Models of metastatic prostate cancer: A transgenic perspective Prostate Cancer Prostatic Dis 6 2003 204 211
31. E.C. Kauffman, V.L. Robinson, and W.M. Stadler Metastasis suppression: The evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site J Urol 169 2003 1122 1133
32. M.S. Bhandari, D.P. Petrylak, and M. Hussain Clinical trials in metastatic prostate cancer - has there been real progress in the past decade? Eur J Cancer 41 2005 941 953
33. S. Gutman, and L.G. Kessler The US Food and Drug Administration perspective on cancer biomarker development Nat Rev Cancer 6 2006 565 571
34. D.C. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 2008 61 70
35. S.M. Lens, G. Vader, and R.H. Medema The case for Survivin as mitotic regulator Curr Opin Cell Biol 18 2006 616 622
36. A.C. Mita, M.M. Mita, and S.T. Nawrocki Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics Clin Cancer Res 14 2008 5000 5005
37. T. Bogenrieder, and M. Herlyn Axis of evil: Molecular mechanisms of cancer metastasis Oncogene 22 2003 6524 6536
38. W.G. Jiang, M.C. Puntis, and M.B. Hallett Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment Br J Surg 81 1994 1576 1590
39. E.C. Woodhouse, R.F. Chuaqui, and L.A. Liotta General mechanisms of metastasis Cancer 80 1997 1529 1537
40. V.L. Robinson, E.C. Kauffman, and M.H. Sokoloff The basic biology of metastasis Cancer Treat Res 118 2004 1 21
41. D.C. Altieri The case for survivin as a regulator of microtubule dynamics and cell-death decisions Curr Opin Cell Biol 18 2006 609 615
42. A. Giodini, M.J. Kallio, and N.R. Wall Regulation of microtubule stability and mitotic progression by survivin Cancer Res 62 2002 2462 2467
43. H. Okada, C. Bakal, and A. Shahinian Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death J Exp Med 199 2004 399 410